{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:30:16Z","timestamp":1792085416343,"version":"4.4.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.clinthera.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T20:31:14Z","timestamp":1485808274000},"page":"378-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review"],"prefix":"10.1016","volume":"39","author":[{"given":"Marko","family":"Skelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Lucijani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Amid\u017ei\u0107 Klari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnes","family":"Re\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miro","family":"Bakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Marija","family":"Liberati-\u010cizmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Raheli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.01.005_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/CCO.0000000000000242","article-title":"Update on the treatment of hypothyroidism","volume":"28","author":"Jonklaas","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","article-title":"Conditions and drugs interfering with thyroxine absorption","volume":"23","author":"Liwanpo","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0004-27302010000500002","article-title":"The difficult patient: Drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism","volume":"54","author":"Ward","year":"2010","journal-title":"Arq Brasil Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MED.0000000000000003","article-title":"When thyroid hormone replacement is ineffective?","volume":"20","author":"Benvenga","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.clinthera.2017.01.005_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/thy.1994.4.55","article-title":"Human thyroxine absorption: age effects and methodological analyses","volume":"4","author":"Hays","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1995.5.249","article-title":"Delayed intestinal absorption of levothyroxine","volume":"5","author":"Benvenga","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib8","doi-asserted-by":"crossref","unstructured":"El-Kattan A, Varma M. (2012) Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability. In J. Paxton (Ed.) Topics on Drug Metabolism. InTech, 10.5772\/31087. http:\/\/www.intechopen.com\/books\/topics-on-drug-metabolism\/oral-absorption-intestinal-metabolism-and-human-oral-bioavailability","DOI":"10.5772\/31087"},{"key":"10.1016\/j.clinthera.2017.01.005_bib9","series-title":"Oral drug absorption prediction and assessment","article-title":"Food effects on drug absorption and dosage form performance","author":"Ilertz","year":"2010"},{"key":"10.1016\/j.clinthera.2017.01.005_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2125.2005.02433.x","article-title":"Effects of grapefruit juice on the absorption of levothyroxine","volume":"60","author":"Lilja","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2010.03722.x","article-title":"Fruit juice inhibition of uptake transport: a new type of food-drug interaction","volume":"70","author":"Bailey","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib12","unstructured":"Food and Drug Administration (2016) Medication Error Reports. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/MedicationErrors\/ucm080629.htm. Accessed October 24, 2016."},{"key":"10.1016\/j.clinthera.2017.01.005_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-016-1035-1","article-title":"Liquid and softgel levothyroxine use in clinical practice: state of the art","volume":"54","author":"Virili","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.clinthera.2017.01.005_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4158\/EP13418.OR","article-title":"Comparison of TSH levels with liquid formulation versus tablet formulations of levothyroxine in the treatment of adult hypothyroidism","volume":"20","author":"Brancato","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2017.01.005_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000356047","article-title":"Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine","volume":"81","author":"Peroni","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.clinthera.2017.01.005_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12020-012-9772-2","article-title":"A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations","volume":"43","author":"Vita","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.clinthera.2017.01.005_bib17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","article-title":"Oral liquid L-thyroxine (L-T4) may be better absorbed compared to L-T4 tablets following bariatric surgery","volume":"23","author":"Pirola","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.clinthera.2017.01.005_bib18","first-page":"844","article-title":"When bioequivalence in healthy volunteers may not translate to bioequivalence in patients: differential effects of increased gastric pH on the pharmacokinetics of levothyroxine capsules and tablets","volume":"18","author":"Seng Yue","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2017.01.005_bib19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","article-title":"The administration of L-thyroxine as soft gel capsule or liquid solution","volume":"11","author":"Vita","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.clinthera.2017.01.005_bib20","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.4158\/EP13316.CR","article-title":"Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule","volume":"20","author":"Vita","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2017.01.005_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12020-014-0476-7","article-title":"Thyroxine softgel capsule in patients with gastric-related T4 malabsorption","volume":"49","author":"Santaguida","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.clinthera.2017.01.005_bib22","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1210\/jc.2014-2684","article-title":"Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors","volume":"99","author":"Vita","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib23","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/archinternmed.2010.436","article-title":"Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial","volume":"170","author":"Bolk","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib24","doi-asserted-by":"crossref","first-page":"505239","DOI":"10.4061\/2011\/505239","article-title":"Can levothyroxine be taken as evening dose? Comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism","volume":"2011","author":"Rajput","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.clinthera.2017.01.005_bib25","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1210\/jc.2009-0860","article-title":"Timing of levothyroxine administration affects serum thyrotropin concentration","volume":"94","author":"Bach-Huynh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/thy.2012.0435","article-title":"Serum thyrotropin levels following levothyroxine administration at breakfast","volume":"23","author":"Perez","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1345\/aph.10286","article-title":"Effect of levothyroxine administration time on serum TSH in elderly patients","volume":"35","author":"Elliott","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2017.01.005_bib28","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib29","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3748\/wjg.v13.i11.1715","article-title":"Coeliac disease in Dutch patients with Hashimoto\u05f3s thyroiditis and vice versa","volume":"21","author":"Hadithi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3121\/cmr.2007.738","article-title":"Celiac disease and autoimmune thyroid disease","volume":"5","author":"Ch\u05f3ng","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.clinthera.2017.01.005_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clinthera.2017.01.005_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1590\/S0004-27302005000400020","article-title":"Autoimmune hypothyroidism nonresponsive to high doses of levothyroxine and severe hypocalcemia","volume":"49","author":"Silva","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib33","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2011-1851","article-title":"Atypical celiac disease as cause of increased need for thyroxine: a systematic study","volume":"97","author":"Virili","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjmed.2011.09.003","article-title":"Celiac disease and hypothyroidism","volume":"125","author":"Collins","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bpg.2005.02.004","article-title":"Coeliac disease: is it time for mass screening?","volume":"19","author":"Mearin","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2005.15.386","article-title":"Celiac disease presenting as resistant hypothyroidism","volume":"15","author":"McDermott","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/105072502320288519","article-title":"Gluten-induced enteropathy (coeliac disease) revealed by resistance to treatment with levothyroxine and alfacalcidol in a sixty-eight-year-old patient: a case report","volume":"12","author":"d\u05f3Est\u00e8ve-Bonetti","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/BF03347379","article-title":"Occurrence of overt celiac disease in the elderly following total thyroidectomy","volume":"29","author":"Caputo","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clinthera.2017.01.005_bib39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/thy.2006.16.1171","article-title":"Lactose intolerance revealed by severe resistance to treatment with levothyroxine","volume":"16","author":"Mu\u00f1oz-Torres","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2036.2008.03815.x","article-title":"Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms","volume":"28","author":"Montalto","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.01.005_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12020-013-0065-1","article-title":"Decrease in TSH levels after lactose restriction in Hashimoto\u05f3s thyroiditis patients with lactose intolerance","volume":"46","author":"Asik","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.clinthera.2017.01.005_bib42","doi-asserted-by":"crossref","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","article-title":"Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine","volume":"99","author":"Cellini","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib43","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","article-title":"Helicobacter pylori infection and drugs malabsorption","volume":"20","author":"Lahner","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2006-924980","article-title":"Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy","volume":"38","author":"Dietrich","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinthera.2017.01.005_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1523-5378.2011.00830.x","article-title":"The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine","volume":"16","author":"Bugdaci","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.clinthera.2017.01.005_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0029-1211442","article-title":"Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism\u2014implications for localization of thyroid hormone absorption in the gut","volume":"104","author":"Seppel","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.clinthera.2017.01.005_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0004-27302011000100012","article-title":"Increased levothyroxine requirement in a woman with previously well-controlled hypothyroidism and intestinal giardiasis","volume":"55","author":"de Figueiredo","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjsurg.2006.07.006","article-title":"Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry","volume":"192","author":"Samuel","year":"2006","journal-title":"Am J Surg"},{"key":"10.1016\/j.clinthera.2017.01.005_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","article-title":"A systematic review of drug absorption following bariatric surgery and its theoretical implications","volume":"11","author":"Padwal","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.clinthera.2017.01.005_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11695-011-0452-8","article-title":"Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery","volume":"22","author":"Rubio","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.clinthera.2017.01.005_bib51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/thy.2011.0526","article-title":"Improved levothyroxine pharmacokinetics after bariatric surgery","volume":"23","author":"Gkotsina","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib52","series-title":"Guidance for industry","first-page":"1","article-title":"Food-effect bioavailability and fed bioequivalence studies","year":"2002"},{"key":"10.1016\/j.clinthera.2017.01.005_bib53","unstructured":"Agency for Medicinal Products and Medical Devices. (2015) Euthyrox 100 \u00b5g tablets http:\/\/www.halmed.hr\/upl\/lijekovi\/SPC\/UP-I-530-09-14-01-218.pdf. Accessed January 10, 2015."},{"key":"10.1016\/j.clinthera.2017.01.005_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4236\/ojemd.2012.23005","article-title":"Administration of levothyroxine 45\u201360 min before breakfast improves biochemical availability as evidenced by reduced thyrotropin levels","volume":"2","author":"Seechurn","year":"2012","journal-title":"Open J Endocr Metab Dis"},{"key":"10.1016\/j.clinthera.2017.01.005_bib55","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0884533610385701","article-title":"Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction","volume":"25","author":"Dickerson","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clinthera.2017.01.005_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0026-0495(77)90121-4","article-title":"Aspects of the absorption of oral L-thyroxine in normal man","volume":"26","author":"Wenzel","year":"1977","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.clinthera.2017.01.005_bib57","first-page":"857","article-title":"Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients","volume":"81","author":"Liel","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/thy.2007.0222","article-title":"Altered intestinal absorption of L-thyroxine caused by coffee","volume":"18","author":"Benvenga","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/thy.1998.8.667","article-title":"Effects of pharmacological fiber supplements on levothyroxine absorption","volume":"8","author":"Chiu","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM196507082730205","article-title":"Thyroid refractoriness in an athyreotic cretin fed soybean formula","volume":"273","author":"Pinchera","year":"1965","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib61","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1542\/peds.2011-3350","article-title":"Unawareness of the effects of soy intake on the management of congenital hypothyroidism","volume":"130","author":"Fruzza","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2017.01.005_bib62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/07315724.1997.10718686","article-title":"Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula","volume":"16","author":"Jabbar","year":"1997","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.clinthera.2017.01.005_bib63","first-page":"148","article-title":"Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature","volume":"96","author":"Chorazy","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2017.01.005_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/adc.2002.009365","article-title":"Soy formula complicates management of congenital hypothyroidism","volume":"89","author":"Conrad","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinthera.2017.01.005_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4158\/EP.7.3.193","article-title":"Use of soy protein supplement and resultant need for increased dose of levothyroxine","volume":"7","author":"Bell","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2017.01.005_bib66","first-page":"16","article-title":"Vitamin C improves the apparent absorption of levothyroxine in a subset of patients receiving this hormone for primary hypothyroidism","volume":"48","author":"Ant\u00fanez","year":"2011","journal-title":"Rev Argent Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib67","doi-asserted-by":"crossref","first-page":"E1031","DOI":"10.1210\/jc.2013-4360","article-title":"Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis","volume":"99","author":"Jubiz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2017.01.005_bib68","unstructured":"Lexicomp\u00ae [database on the Internet] Hudson, OH, USA: Lexicomp, Inc; 2013. (2015). http:\/\/webstore.lexi.com\/Information\/Product-Information\/Lexi-Drugs-and-Lexi-Interact-Details. Accessed February 12, 2015."},{"key":"10.1016\/j.clinthera.2017.01.005_bib69","unstructured":"MICROMEDEX\u00ae Gateway [database on the Internet] Greenwood Village, CO, USA: Thomson Reuters. (2013). http:\/\/www.thomsonhc.com\/home. Accessed February 12, 2015."},{"key":"10.1016\/j.clinthera.2017.01.005_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archinte.1992.00400130181024","article-title":"Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide","volume":"152","author":"Sperber","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(94)90303-4","article-title":"Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide","volume":"97","author":"Liel","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0773.1999.tb00883.x","article-title":"Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments","volume":"84","author":"Mersebach","year":"1999","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib73","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/thy.2010.0296","article-title":"Absorption of levothyroxine when coadministered with various calcium formulations","volume":"21","author":"Zamfirescu","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib74","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/105072501753211046","article-title":"The acute effect of calcium carbonate on the intestinal absorption of levothyroxine","volume":"11","author":"Singh","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib75","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1001\/jama.283.21.2822","article-title":"Effect of calcium carbonate on the absorption of levothyroxine","volume":"283","author":"Singh","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2017.01.005_bib76","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.279.10.750-b","article-title":"Calcium carbonate and reduction of levothyroxine efficacy","volume":"279","author":"Schneyer","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2017.01.005_bib77","first-page":"39","article-title":"Interaction between levothyroxine and calcium carbonate","volume":"54","author":"Mazokopakis","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clinthera.2017.01.005_bib78","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-132-7-200004040-00026","article-title":"Calcium carbonate-induced hypothyroidism","volume":"132","author":"Butner","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11255-006-9166-6","article-title":"Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement","volume":"39","author":"Diskin","year":"2007","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib80","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-117-12-1010","article-title":"Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism","volume":"117","author":"Campbell","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib81","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00007611-199706000-00011","article-title":"Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism","volume":"90","author":"Shakir","year":"1997","journal-title":"South Med J"},{"key":"10.1016\/j.clinthera.2017.01.005_bib82","first-page":"492","article-title":"Increased need for thyroxine induced by iron sulfate","volume":"23","author":"Schlienger","year":"1994","journal-title":"Presse Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib83","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.revmed.2009.09.038","article-title":"Hypothyroidism as the result of drug interaction between ferrous sulfate and levothyroxine","volume":"31","author":"Fiaux","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.clinthera.2017.01.005_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/thy.2008.0312","article-title":"Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine","volume":"19","author":"Weitzman","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib85","unstructured":"Medicines and Healthcare Products Regulatory Agency (2015) SPC-DOC_PL 08081-0044.PDF. http:\/\/www.mhra.gov.uk\/home\/groups\/spcpil\/documents\/spcpil\/con1386830026231.pdf. Accessed January 28, 2015."},{"key":"10.1016\/j.clinthera.2017.01.005_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.clon.2005.05.001","article-title":"Hypothyroidism in thyroid carcinoma follow-up: orlistat may inhibit the absorption of thyroxine","volume":"17","author":"Madhava","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clinthera.2017.01.005_bib87","unstructured":"Medicines and Healthcare Products Regulatory Agency (2015) SPC-DOC_PL 30306-0380.PDF. http:\/\/www.mhra.gov.uk\/home\/groups\/spcpil\/documents\/spcpil\/con1426827504895.pdf. Accessed January 28, 2015."},{"key":"10.1016\/j.clinthera.2017.01.005_bib88","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/0140-6736(93)91195-R","article-title":"Cation-exchange resin and inhibition of intestinal absorption of thyroxine","volume":"341","author":"Mclean","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2017.01.005_bib89","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/archinte.163.11.1367","article-title":"Raloxifene causing malabsorption of levothyroxine","volume":"163","author":"Siraj","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib90","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1592\/phco.26.6.881","article-title":"Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene","volume":"26","author":"Garwood","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2017.01.005_bib91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12020-008-9107-5","article-title":"Low doses of cholestyramine in the treatment of hyperthyroidism","volume":"34","author":"Kaykhaei","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.clinthera.2017.01.005_bib92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF03348036","article-title":"Role of colestipol in the treatment of hyperthyroidism","volume":"21","author":"Hagag","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clinthera.2017.01.005_bib93","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0091270009349378","article-title":"Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen, estradiol, norethindrone, levothyroxine, and glyburide","volume":"50","author":"Brown","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.01.005_bib94","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.1969.03160100047012","article-title":"The influence of cholestyramine on thyroxine absorption","volume":"208","author":"Northcutt","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2017.01.005_bib95","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-115-8-658_2","article-title":"Levothyroxine-cholestyramine interaction reemphasized","volume":"115","author":"Harmon","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib96","first-page":"109","article-title":"Malabsorption of thyroid hormone with cholestyramine administration","volume":"58","author":"Rosenberg","year":"1994","journal-title":"Conn Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-118-2-199301150-00006","article-title":"The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism","volume":"118","author":"Shakir","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib98","first-page":"61","article-title":"Light symptoms following a high-dose intentional L-thyroxine ingestion treated with cholestyramine","volume":"57","author":"de Luis","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.clinthera.2017.01.005_bib99","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ndt\/gfm615","article-title":"Phosphate binders and timing of levothyroxine administration","volume":"23","author":"Arnadottir","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2017.01.005_bib100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2007.0060","article-title":"New medications which decrease levothyroxine absorption","volume":"17","author":"John-Kalarickal","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib101","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/archdischild-2011-300333","article-title":"Drug interaction of levothyroxine with infant colic drops","volume":"96","author":"Balapatabendi","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinthera.2017.01.005_bib102","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1089\/thy.2013.0014","article-title":"Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption","volume":"23","author":"Goldberg","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib103","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/bmj.330.7498.1002","article-title":"Ciprofloxacin interacts with thyroid replacement therapy","volume":"330","author":"Cooper","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2017.01.005_bib104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00007611-199905000-00018","article-title":"Interaction between rifampin and levothyroxine","volume":"92","author":"Nolan","year":"1999","journal-title":"South Med J"},{"key":"10.1016\/j.clinthera.2017.01.005_bib105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF03344165","article-title":"Rifampin-induced hypothyroidism","volume":"29","author":"Takasu","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clinthera.2017.01.005_bib106","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-117-5-445_3","article-title":"Levothyroxine binding by sucralfate","volume":"117","author":"Havrankova","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib107","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9343(94)90093-0","article-title":"Sucralfate causes malabsorption of L-thyroxine","volume":"96","author":"Sherman","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib108","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-118-4-199302150-00027","article-title":"Does sucralfate impede levothyroxine therapy","volume":"118","author":"Khan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-121-2-199407150-00024","article-title":"Sucralfate and the absorption of L-thyroxine","volume":"121","author":"Campbell","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.01.005_bib110","first-page":"391","article-title":"Effect of cimetidine and ranitidine on absorption of [125I] levothyroxine administered orally","volume":"13","author":"Jonderko","year":"1992","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.clinthera.2017.01.005_bib111","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/thy.2007.0381","article-title":"The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption","volume":"18","author":"Ananthakrishnan","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.clinthera.2017.01.005_bib112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cen.12559","article-title":"Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS)","volume":"82","author":"Irving","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clinthera.2017.01.005_bib113","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4158\/EP.13.4.345","article-title":"Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism","volume":"13","author":"Sachmechi","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2017.01.005_bib114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40261-015-0271-0","article-title":"Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice","volume":"35","author":"Trifir\u00f2","year":"2015","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.clinthera.2017.01.005_bib115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejpb.2008.10.008","article-title":"A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry","volume":"72","author":"Pabla","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.clinthera.2017.01.005_bib116","doi-asserted-by":"crossref","first-page":"40","DOI":"10.17925\/EE.2013.09.01.40","article-title":"A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism","volume":"9","author":"Colucci","year":"2013","journal-title":"Eur Endocrinol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817300383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817300383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:30:51Z","timestamp":1568763051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817300383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0149291817300383"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.01.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}